National Institute of Mental Health (NIMH); Notice of Meeting, 52479-52480 [2021-20424]

Download as PDF Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2021–20324 Filed 9–20–21; 8:45 am] National Institutes of Health National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting National Institute of Mental Health (NIMH); Notice of Meeting BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed). Date: October 18–19, 2021. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G62A, Rockville, MD 20892 (Virtual Meeting). Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G62A, Rockville, MD 20852, (240) 669–5081, ecohen@ niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) lotter on DSK11XQN23PROD with NOTICES1 52479 Dated: September 15, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–20370 Filed 9–20–21; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board. The meeting will be held as a virtual meeting and open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH video https:// videocast.nih.gov/ and the CCRHB website https://ccrhb.od.nih.gov/ meetings.html. Name of Committee: NIH Clinical Center Research Hospital Board. Date: October 15, 2021. Time: 9:00 a.m. to 1:00 p.m. Agenda: CC CEO Update, Patient Safety and Clinical Quality Update, other business of the Board. Place: National Institutes of Health, Building 1, 9000 Rockville Pike, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301–496–4272, woodgs@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: September 15, 2021. Patricia B. Hansberger, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–20369 Filed 9–20–21; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 21:03 Sep 20, 2021 Jkt 253001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Interagency Autism Coordinating Committee. The purpose of the IACC meeting is to discuss business, agency updates, and issues related to autism spectrum disorder (ASD) research and services activities. The meeting will be held as a virtual meeting and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below at least seven (7) business days in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocast website (https://videocast.nih.gov/). Name of Committee: Interagency Autism Coordinating Committee (IACC). Date: October 13–14, 2021 Meeting schedule subject to change. Time: 1:00 p.m. to 5:00 p.m. Meeting Access: Wednesday, October 13, 2021 https://videocast.nih.gov/watch=42377 Thursday, October 14, 2021 https://videocast. nih.gov/watch=42378. Agenda: To discuss business, updates, and issues related to ASD research and services activities. Cost: The meeting is free and open to the public. Registration: A registration web link will be posted on the IACC website (www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended. Deadlines: Written/Virtual Public Comment Due Date: Friday, October 1, 2021, by 5:00 p.m. ET, For instructions, see below. Contact Person: Ms. Rebecca Martin, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Bethesda, MD 20892– 9669, Phone: 301–435–0886, Email: IACCPublicInquiries@mail.nih.gov. Public Comments The IACC welcomes public comments from members of the autism community. As the IACC will be updating its Strategic Plan, comments related to issues that the community would like to see highlighted in the new IACC Strategic Plan are welcome. Comments may be submitted in writing via email to IACCPublicInquiries@ mail.nih.gov or using the web form at: https://iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 p.m. ET on Friday, October 1, 2021. A limited number of slots are available for E:\FR\FM\21SEN1.SGM 21SEN1 52480 Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices individuals to provide a 2–3-minute summary or excerpt of their written comment to the Committee live during the virtual meeting using the virtual platform. For those interested in that opportunity, please indicate ‘‘Interested in providing virtual comment’’ in your written submission, along with your name, address, email, phone number, and professional/organizational affiliation so that OARC staff can contact you if a slot is available for you to provide a summary or excerpt of your comment via the virtual platform during the meeting. For any given meeting, priority for virtual comment slots will be given to commenters who have not previously provided virtual comments in the current calendar year. This will help ensure that as many individuals as possible have an opportunity to share comments. Commenters going over their allotted 3-minute slot may be asked to conclude immediately to allow other comments and the rest of the meeting to proceed on schedule. Public comments received by 5:00 p.m. ET on Friday, October 1, 2021, will be provided to the IACC prior to the meeting for their consideration. Any written comments received after 5:00 p.m. ET, October 1, 2021, may be provided to the IACC either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. The IACC is not able to individually respond to comments. All public comments become part of the public record. Attachments of copyrighted publications are not permitted, but web links or citations for any copyrighted works cited may be provided. For public comment guidelines, see: https:// iacc.hhs.gov/meetings/publiccomments/guidelines/. lotter on DSK11XQN23PROD with NOTICES1 Technical Issues If you experience any technical problems with the webcast, please email IACCPublicInquiries@mail.nih.gov. Disability Accommodations All IACC Full Meetings provide Closed Captioning through the NIH videocast website. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language or interpreting services, etc.) must submit a request to the Contact Person listed on the notice at least seven (7) business days prior to the meeting. Such requests should include a detailed description of the accommodation needed and a way for the IACC to contact the requester if more information is needed to fill the VerDate Sep<11>2014 21:03 Sep 20, 2021 Jkt 253001 request. Last-minute requests may be made, but may not be possible to accommodate. National Institutes of Health Additional Information Information about the IACC is available on the website: https:// www.iacc.hhs.gov. Dated: September 16, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–20424 Filed 9–20–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Inherited Disease Research Access Committee CIDR. Date: November 5, 2021. Time: 11:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3100, Room 3185, Bethesda, MD 20892–6908 (Virtual Meeting). Contact Person: Barbara J. Thomas, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Suite 3100, Room 3185, Bethesda, MD 20892–6908, 301–402–8837, barbara.thomas@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: September 15, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–20374 Filed 9–20–21; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Environmental Health Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Environmental Health Sciences Review Committee. Date: October 4–6, 2021. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute Environmental Health Sciences, Keystone Building, 530 Davis Drive, Research Triangle Park, NC 27713 (Virtual Meeting). Contact Person: Linda K. Bass, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, 984–287– 3236, bass@niehs.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Environmental Health Sciences Review Committee. Date: November 9, 2021. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute Environmental Health Sciences, Keystone Building, 530 Davis Drive, Research Triangle Park, NC 27713 (Virtual Meeting). Contact Person: Linda K. Bass, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, 984–287– 3236, bass@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health E:\FR\FM\21SEN1.SGM 21SEN1

Agencies

[Federal Register Volume 86, Number 180 (Tuesday, September 21, 2021)]
[Notices]
[Pages 52479-52480]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20424]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health (NIMH); Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Interagency Autism 
Coordinating Committee.
    The purpose of the IACC meeting is to discuss business, agency 
updates, and issues related to autism spectrum disorder (ASD) research 
and services activities. The meeting will be held as a virtual meeting 
and is open to the public. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below at 
least seven (7) business days in advance of the meeting. The open 
session will be videocast and can be accessed from the NIH Videocast 
website (https://videocast.nih.gov/).

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC).
    Date: October 13-14, 2021 Meeting schedule subject to change.
    Time: 1:00 p.m. to 5:00 p.m.
    Meeting Access: Wednesday, October 13, 2021 https://videocast.nih.gov/watch=42377 Thursday, October 14, 2021 https://videocast.nih.gov/watch=42378.
    Agenda: To discuss business, updates, and issues related to ASD 
research and services activities.
    Cost: The meeting is free and open to the public.
    Registration: A registration web link will be posted on the IACC 
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is 
recommended.
    Deadlines: Written/Virtual Public Comment Due Date: Friday, 
October 1, 2021, by 5:00 p.m. ET, For instructions, see below.
    Contact Person: Ms. Rebecca Martin, Office of Autism Research 
Coordination, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Bethesda, MD 20892-9669, Phone: 301-435-0886, 
Email: [email protected].

Public Comments

    The IACC welcomes public comments from members of the autism 
community. As the IACC will be updating its Strategic Plan, comments 
related to issues that the community would like to see highlighted in 
the new IACC Strategic Plan are welcome. Comments may be submitted in 
writing via email to [email protected] or using the web 
form at: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp 
by 5:00 p.m. ET on Friday, October 1, 2021. A limited number of slots 
are available for

[[Page 52480]]

individuals to provide a 2-3-minute summary or excerpt of their written 
comment to the Committee live during the virtual meeting using the 
virtual platform. For those interested in that opportunity, please 
indicate ``Interested in providing virtual comment'' in your written 
submission, along with your name, address, email, phone number, and 
professional/organizational affiliation so that OARC staff can contact 
you if a slot is available for you to provide a summary or excerpt of 
your comment via the virtual platform during the meeting. For any given 
meeting, priority for virtual comment slots will be given to commenters 
who have not previously provided virtual comments in the current 
calendar year. This will help ensure that as many individuals as 
possible have an opportunity to share comments. Commenters going over 
their allotted 3-minute slot may be asked to conclude immediately to 
allow other comments and the rest of the meeting to proceed on 
schedule.
    Public comments received by 5:00 p.m. ET on Friday, October 1, 
2021, will be provided to the IACC prior to the meeting for their 
consideration. Any written comments received after 5:00 p.m. ET, 
October 1, 2021, may be provided to the IACC either before or after the 
meeting, depending on the volume of comments received and the time 
required to process them in accordance with privacy regulations and 
other applicable Federal policies. The IACC is not able to individually 
respond to comments. All public comments become part of the public 
record. Attachments of copyrighted publications are not permitted, but 
web links or citations for any copyrighted works cited may be provided. 
For public comment guidelines, see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.

Technical Issues

    If you experience any technical problems with the webcast, please 
email [email protected].

Disability Accommodations

    All IACC Full Meetings provide Closed Captioning through the NIH 
videocast website. Individuals whose full participation in the meeting 
will require special accommodations (e.g., sign language or 
interpreting services, etc.) must submit a request to the Contact 
Person listed on the notice at least seven (7) business days prior to 
the meeting. Such requests should include a detailed description of the 
accommodation needed and a way for the IACC to contact the requester if 
more information is needed to fill the request. Last-minute requests 
may be made, but may not be possible to accommodate.

Additional Information

    Information about the IACC is available on the website: https://www.iacc.hhs.gov.

    Dated: September 16, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20424 Filed 9-20-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.